Aureos South Asia Fund (Holdings)
- Active: Active
- Region: Asia & Pacific
- Country: Regional
- Sector: Investment funds
- Year: 2006
- Domicile: Mauritius
- Instrument: Fund
- Commitment (MNOK) as of 31.12.2019: 42.1
- Original Commitment (MNOK): 111.0
Regional fund covering India, Bangladesh and Sri Lanka. USD 85 million fund managed by Abraaj (initially Aureos),with FMO, CDC and Transcentury as largest co-investors.
Aureos South Asia Fund is a loan and equity capital fund investing in small- and medium-sized enterprises in India, Sri Lanka and Bangladesh. Our largest co-investors are CDC and ADB.
Aureos Capital Limited (Aureos)
Aureos Capital Limited (Aureos) was established in July 2001 as a joint venture between the CDC and Norfund. The objective of the joint venture was to create a strong fund manager in a market where there were no strong players, and to enabling the mobilisation of capital to develop countries far beyond what Norfund and CDC could do alone.
Aureos grew to be a global leading SME PE fund manager in emerging and developing markets. By delivering good financial results over time, Aureos succeeded in attracting an increasing proportion of private capital to the funds. Today, ‘non-DFI investors’ (including corporates, family offices, financial institutions and pension funds) is the Fund’s largest investor category. The DFI’s additional role as an investor base of the Aureos funds, as well as owners of the fund manager, diminished accordingly over time. Today, Aureos is incorporated in the Abraaj Capital, a leading private equity investor in emerging markets.
Norfund exited Aureos Capital in 2009, but continues as an investor in the funds.